Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

Market Cap	1.31T +16.1%
Revenue (ttm)	515.53B +29.7%
Net Income	173.97B +36.6%
EPS	8,091.45 +36.6%
Shares Out	21.50M
PE Ratio	7.50
Forward PE	n/a
Dividend	4,000.00 (6.59%)
Ex-Dividend Date	Mar 20, 2026

Volume	5,505
Open	60,300
Previous Close	60,500
Day's Range	60,000 - 60,800
52-Week Range	47,000 - 67,500
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 20, 2026

About HNX:DP3

Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturin...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DP3

Financial Performance

In 2025, HNX:DP3's revenue was 437.93 billion, an increase of 4.90% compared to the previous year's 417.49 billion. Earnings were 156.07 billion, an increase of 28.80%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 3, 2026

Data Sources Report a data error